Susquehanna International Group
MURA

Susquehanna International Group’s Mural Oncology MURA Stock Holding History

Susquehanna International Group’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-132,695
Closed -$285K – 13362
2025
Q2 		$328K Buy
132,695
+7,491
+6% +$17.7K ﹤0.01% 10138
2025
Q1 		$158K Buy
125,204
+38,839
+45% +$142K ﹤0.01% 11181
2024
Q4 		$278K Buy
86,365
+3,101
+4% +$10.9K ﹤0.01% 9999
2024
Q3 		$261K Buy
83,264
+2,454
+3% +$7.99K ﹤0.01% 9906
2024
Q2 		$254K Sell
80,810
-13,767
-15% -$50.7K ﹤0.01% 9824
2024
Q1 		$462K Sell
94,577
-48,269
-34% -$234K ﹤0.01% 8680
2023
Q4 		$846K Buy
+142,846
New +$574K ﹤0.01% 7395

Susquehanna International Group's MURA Position: Q3 2025 in Review

Susquehanna International Group sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 132,695 shares — an estimated $285K sold.

Susquehanna International Group first reported a position in MURA in Q4 2023 and held it in 7 quarters. The position peaked at $846K in Q4 2023. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

  • Susquehanna International Group reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 132,695 Mural Oncology shares in Q3 2025, an estimated $285K.
  • Susquehanna International Group first reported a position in Mural Oncology in Q4 2023 and held it in 7 quarters.
  • Susquehanna International Group's Mural Oncology position peaked at $846K in Q4 2023.
  • 61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.